Inhibition of astroglial NF-kappaB enhances oligodendrogenesis following spinal cord injury

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Bracchi Ricard, Valerie ^a   Lambertsen, Kate L ^a,b   Ricard, Jerome ^a   Nathanson, Lubov ^c   Karmally, Shaffiat ^a   Johnstone, Joshua ^a   Ellman, Ditte G ^b   Frydel, Beata ^a   McTigue, Dana M ^d   Bethea, John R ^a  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

Astrocyte; CXCR4; Microglia; NF kappaB; Oligodendrocyte; Spinal cord injury; TNFR2; Toll like receptor

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GLIAL FIBRILLARY ACIDIC PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEOLIPID PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HISTOGENESIS; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE; MACROGLIA; MICROARRAY ANALYSIS; MICROGLIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGENESIS; OLIGODENDROGLIA; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPINAL CORD INJURY; TRANSGENIC MOUSE; WILD TYPE;

EID: 84880334668     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-92     Document Type: Article

References (63)

1. Donnelly DJ, Popovich PG. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008, 209:378-388. 10.1016/j.expneurol.2007.06.009, 2692462, 17662717.
2. Tripathi R, McTigue DM. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia 2007, 55:698-711. 10.1002/glia.20491, 17330874.
3. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat Rev Neurosci 2008, 9:839-855. 10.1038/nrn2480, 18931697.
4. Kremer D, Aktas O, Hartung HP, Kury P. The complex world of oligodendroglial differentiation inhibitors. Ann Neurol 2011, 69:602-618. 10.1002/ana.22415, 21520230.
5. Kotter MR, Li WW, Zhao C, Franklin RJ. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 2006, 26:328-332. 10.1523/JNEUROSCI.2615-05.2006, 16399703.
6. Brambilla R, Persaud T, Hu X, Karmally S, Shestopalov VI, Dvoriantchikova G, Ivanov D, Nathanson L, Barnum SR, Bethea JR. Transgenic inhibition of astroglial NF-kappa B improves functional outcome in experimental autoimmune encephalomyelitis by suppressing chronic central nervous system inflammation. J Immunol 2009, 182:2628-2640. 10.4049/jimmunol.0802954, 19234157.
7. Moore CS, Abdullah SL, Brown A, Arulpragasam A, Crocker SJ. How factors secreted from astrocytes impact myelin repair. J Neurosci Res 2011, 89:13-21. 10.1002/jnr.22482, 20857501.
8. Moore CS, Milner R, Nishiyama A, Frausto RF, Serwanski DR, Pagarigan RR, Whitton JL, Miller RH, Crocker SJ. Astrocytic tissue inhibitor of metalloproteinase-1 (TIMP-1) promotes oligodendrocyte differentiation and enhances CNS myelination. J Neurosci 2011, 31:6247-6254. 10.1523/JNEUROSCI.5474-10.2011, 3090636, 21508247.
9. Khorooshi R, Babcock AA, Owens T. NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J Immunol 2008, 181:7284-7291.
10. Nash B, Thomson CE, Linington C, Arthur AT, McClure JD, McBride MW, Barnett SC. Functional duality of astrocytes in myelination. J Neurosci 2011, 31:13028-13038. 10.1523/JNEUROSCI.1449-11.2011, 21917786.
11. Wang Y, Cheng X, He Q, Zheng Y, Kim DH, Whittemore SR, Cao QL. Astrocytes from the contused spinal cord inhibit oligodendrocyte differentiation of adult oligodendrocyte precursor cells by increasing the expression of bone morphogenetic proteins. J Neurosci 2011, 31:6053-6058. 10.1523/JNEUROSCI.5524-09.2011, 3081104, 21508230.
12. Brambilla R, Bracchi-Ricard V, Hu WH, Frydel B, Bramwell A, Karmally S, Green EJ, Bethea JR. Inhibition of astroglial nuclear factor kappaB reduces inflammation and improves functional recovery after spinal cord injury. J Exp Med 2005, 202:145-156. 10.1084/jem.20041918, 2212896, 15998793.
13. Brambilla R, Hurtado A, Persaud T, Esham K, Pearse DD, Oudega M, Bethea JR. Transgenic inhibition of astroglial NF-kappa B leads to increased axonal sparing and sprouting following spinal cord injury. J Neurochem 2009, 110:765-778. 10.1111/j.1471-4159.2009.06190.x, 19522780.
14. Lambertsen KL, Gregersen R, Drojdahl N, Owens T, Finsen B. A specific a sensitive method for visualization of tumor necrosis factor in the murine central nervous system. Brain Res Brain Res Protoc 2001, 7:175-191. 10.1016/S1385-299X(01)00062-9, 11356385.
15. Lambertsen KL, Gregersen R, Finsen B. Microglial-macrophage synthesis of tumor necrosis factor after focal cerebral ischemia in mice is strain dependent. J Cereb Blood Flow Metab 2002, 22:785-797.
16. West MJ, Ostergaard K, Andreassen OA, Finsen B. Estimation of the number of somatostatin neurons in the striatum: an in situ hybridization study using the optical fractionator method. J Comp Neurol 1996, 370:11-22. 10.1002/(SICI)1096-9861(19960617)370:1<11::AID-CNE2>3.0.CO;2-O, 8797153.
17. Smyth GK, Michaud J, Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics 2005, 21:2067-2075. 10.1093/bioinformatics/bti270, 15657102.
18. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3:3.
19. Smyth GK, Speed T. Normalization of cDNA microarray data. Methods 2003, 31:265-273. 10.1016/S1046-2023(03)00155-5, 14597310.
20. Draghici S, Khatri P, Tarca AL, Amin K, Done A, Voichita C, Georgescu C, Romero R. A systems biology approach for pathway level analysis. Genome Res 2007, 17:1537-1545. 10.1101/gr.6202607, 1987343, 17785539.
21. Zhang B, Kirov S, Snoddy J. WebGestalt: an integrated system for exploring gene sets in various biological contexts. Nucleic Acids Res 2005, 33:W741-W748. 10.1093/nar/gki475, 1160236, 15980575.
22. Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso Mouse Scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma 2006, 23:635-659. 10.1089/neu.2006.23.635, 16689667.
23. Nishiyama A, Komitova M, Suzuki R, Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci 2009, 10:9-22.
24. Mi S, Hu B, Hahm K, Luo Y, Kam Hui ES, Yuan Q, Wong WM, Wang L, Su H, Chu TH, Guo J, Zhang W, So KF, Pepinsky B, Shao Z, Graff C, Garber E, Jung V, Wu EX, Wu W. LINGO-1 antagonist promotes spinal cord remyelination and axonal integrity in MOG-induced experimental autoimmune encephalomyelitis. Nat Med 2007, 13:1228-1233. 10.1038/nm1664, 17906634.
25. Chew LJ, Shen W, Ming X, Senatorov VV, Chen HL, Cheng Y, Hong E, Knoblach S, Gallo V. SRY-box containing gene 17 regulates the Wnt/beta-catenin signaling pathway in oligodendrocyte progenitor cells. J Neurosci 2011, 31:13921-13935. 10.1523/JNEUROSCI.3343-11.2011, 3227525, 21957254.
26. Sohn J, Natale J, Chew LJ, Belachew S, Cheng Y, Aguirre A, Lytle J, Nait-Oumesmar B, Kerninon C, Kanai-Azuma M, Kanai Y, Gallo V. Identification of Sox17 as a transcription factor that regulates oligodendrocyte development. J Neurosci 2006, 26:9722-9735. 10.1523/JNEUROSCI.1716-06.2006, 16988043.
27. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB. LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005, 8:745-751. 10.1038/nn1460, 15895088.
28. Clausen BH, Lambertsen KL, Meldgaard M, Finsen B. A quantitative in situ hybridization and polymerase chain reaction study of microglial-macrophage expression of interleukin-1beta mRNA following permanent middle cerebral artery occlusion in mice. Neuroscience 2005, 132:879-892. 10.1016/j.neuroscience.2005.01.031, 15857694.
29. Lambertsen KL, Clausen BH, Babcock AA, Gregersen R, Fenger C, Nielsen HH, Haugaard LS, Wirenfeldt M, Nielsen M, Dagnaes-Hansen F, Bluethmann H, Faergeman NJ, Meldgaard M, Deierborg T, Finsen B. Microglia protect neurons against ischemia by synthesis of tumor necrosis factor. J Neurosci 2009, 29:1319-1330. 10.1523/JNEUROSCI.5505-08.2009, 19193879.
30. Clausen BH, Lambertsen KL, Babcock AA, Holm TH, Dagnaes-Hansen F, Finsen B. Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice. J Neuroinflammation 2008, 5:46. 10.1186/1742-2094-5-46, 2585073, 18947400.
31. Glezer I, Lapointe A, Rivest S. Innate immunity triggers oligodendrocyte progenitor reactivity and confines damages to brain injuries. FASEB J 2006, 20:750-752.
32. Loane DJ, Byrnes KR. Role of microglia in neurotrauma. Neurotherapeutics 2010, 7:366-377. 10.1016/j.nurt.2010.07.002, 2948548, 20880501.
33. Olah M, Amor S, Brouwer N, Vinet J, Eggen B, Biber K, Boddeke HW. Identification of a microglia phenotype supportive of remyelination. Glia 2011, 60:306-321.
34. Schonberg DL, Popovich PG, McTigue DM. Oligodendrocyte generation is differentially influenced by toll-like receptor (TLR) 2 and TLR4-mediated intraspinal macrophage activation. J Neuropathol Exp Neurol 2007, 66:1124-1135. 10.1097/nen.0b013e31815c2530, 18090921.
35. Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009, 29:13435-13444. 10.1523/JNEUROSCI.3257-09.2009, 2788152, 19864556.
36. Kigerl KA, Lai W, Rivest S, Hart RP, Satoskar AR, Popovich PG. Toll-like receptor (TLR)-2 and TLR-4 regulate inflammation, gliosis, and myelin sparing after spinal cord injury. J Neurochem 2007, 102:37-50. 10.1111/j.1471-4159.2007.04524.x, 17403033.
37. Bajetto A, Bonavia R, Barbero S, Florio T, Schettini G. Chemokines and their receptors in the central nervous system. Front Neuroendocrinol 2001, 22:147-184. 10.1006/frne.2001.0214, 11456467.
38. Dziembowska M, Tham TN, Lau P, Vitry S, Lazarini F, Dubois-Dalcq M. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia 2005, 50:258-269. 10.1002/glia.20170, 15756692.
39. Li M, Chang CJ, Lathia JD, Wang L, Pacenta HL, Cotleur A, Ransohoff RM. Chemokine receptor CXCR4 signaling modulates the growth factor-induced cell cycle of self-renewing and multipotent neural progenitor cells. Glia 2011, 59:108-118. 10.1002/glia.21080, 21046557.
40. Opatz J, Kury P, Schiwy N, Jarve A, Estrada V, Brazda N, Bosse F, Muller HW. SDF-1 stimulates neurite growth on inhibitory CNS myelin. Mol Cell Neurosci 2009, 40:293-300. 10.1016/j.mcn.2008.11.002, 19084600.
41. Banisadr G, Frederick TJ, Freitag C, Ren D, Jung H, Miller SD, Miller RJ. The role of CXCR4 signaling in the migration of transplanted oligodendrocyte progenitors into the cerebral white matter. Neurobiol Dis 2011, 44:19-27.
42. Carbajal KS, Miranda JL, Tsukamoto MR, Lane TE. CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia 2011, 59:1813-1821. 10.1002/glia.21225, 21830237.
43. Petty JM, Sueblinvong V, Lenox CC, Jones CC, Cosgrove GP, Cool CD, Rai PR, Brown KK, Weiss DJ, Poynter ME, Suratt BT. Pulmonary stromal-derived factor-1 expression and effect on neutrophil recruitment during acute lung injury. J Immunol 2007, 178:8148-8157.
44. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA. A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 1996, 184:1101-1109. 10.1084/jem.184.3.1101, 2192798, 9064327.
45. Hayashi H, Kume T. Forkhead transcription factors regulate expression of the chemokine receptor CXCR4 in endothelial cells and CXCL12-induced cell migration. Biochem Biophys Res Commun 2008, 367:584-589. 10.1016/j.bbrc.2007.12.183, 2265419, 18187037.
46. Cruz-Orengo L, Chen YJ, Kim JH, Dorsey D, Song SK, Klein RS. CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity. J Neuroinflammation 2011, 8:170. 10.1186/1742-2094-8-170, 3305694, 22145790.
47. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 2001, 4:1116-1122. 10.1038/nn738, 11600888.
48. Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE, Bethea JR. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain 2011, 134:2736-2754. 10.1093/brain/awr199, 3170538, 21908877.
49. Lambertsen KL, Clausen BH, Fenger C, Wulf H, Owens T, Dagnaes-Hansen F, Meldgaard M, Finsen B. Microglia and macrophages express tumor necrosis factor receptor p75 following middle cerebral artery occlusion in mice. Neuroscience 2007, 144:934-949. 10.1016/j.neuroscience.2006.10.046, 17161916.
50. Wu J, Yoo S, Wilcock D, Lytle JM, Leung PY, Colton CA, Wrathall JR. Interaction of NG2(+) glial progenitors and microglia/macrophages from the injured spinal cord. Glia 2010, 58:410-422. 2807472, 19780197.
51. Foote AK, Blakemore WF. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 2005, 128:528-539. 10.1093/brain/awh417, 15699059.
52. Hvilsted Nielsen H, Toft-Hansen H, Lambertsen KL, Owens T, Finsen B. Stimulation of adult oligodendrogenesis by myelin-specific T cells. Am J Pathol 2011, 179:2028-2041. 10.1016/j.ajpath.2011.06.006, 3181396, 21872562.
53. Kostianovsky AM, Maier LM, Anderson RC, Bruce JN, Anderson DE. Astrocytic regulation of human monocytic/microglial activation. J Immunol 2008, 181:5425-5432.
54. Ubogu EE, Cossoy MB, Ransohoff RM. The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 2006, 27:48-55. 10.1016/j.tips.2005.11.002, 16310865.
55. Han Y, Wang J, He T, Ransohoff RM. TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res 2001, 888:1-10. 10.1016/S0006-8993(00)02924-3, 11146046.
56. Patel JR, McCandless EE, Dorsey D, Klein RS. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc Natl Acad Sci U S A 2010, 107:11062-11067. 10.1073/pnas.1006301107, 2890706, 20534485.
57. Gottle P, Kremer D, Jander S, Odemis V, Engele J, Hartung HP, Kury P. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann Neurol 2010, 68:915-924. 10.1002/ana.22214, 21154415.
58. Wang L, Wang Z, Yang B, Yang Q, Wang L, Sun Y. CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma. Oncol Rep 2009, 22:1333-1339.
59. Farooque M, Isaksson J, Olsson Y. Improved recovery after spinal cord injury in neuronal nitric oxide synthase-deficient mice but not in TNF-alpha-deficient mice. J Neurotrauma 2001, 18:105-114. 10.1089/089771501750055811, 11200245.
60. Patel JR, Williams JL, Muccigrosso MM, Liu L, Sun T, Rubin JB, Klein RS. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta Neuropathol 2012, 124:847-860. 10.1007/s00401-012-1034-0, 3508279, 22933014.
61. Kigerl KA, McGaughy VM, Popovich PG. Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol 2006, 494:578-594. 10.1002/cne.20827, 2655318, 16374800.
62. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG. Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 2003, 462:223-240. 10.1002/cne.10736, 12794745.
63. Trivedi A, Olivas AD, Noble-Haeusslein LJ. Inflammation and spinal cord injury: infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res 2006, 6:283-292. 10.1016/j.cnr.2006.09.007, 1864937, 18059979.